Innovative solutions to the greatest challenges in pharmaceutical development

9th – 11th March 2020 | Berlin

The perfect mix. The DDF Summit brings together leading formulation development, drug delivery and device development professionals from both industry and academia to share and discuss their latest work.

Quality content. The agenda is packed with carefully selected talks on topics as diverse as the challenges you face.

Invaluable networking. The DDF community is open, friendly and represents and incredibly valuable network of scientists working at the forefront of their field. There is ample networking time built in to help you make and strengthen connections.

Tailor your experience. 4 parallel streams give you the chance to personalise your agenda and delve deep into the topics pertinent to your challenges. Choose from Small Molecules, Biologics, Technology & Innovation or Device Development.

The right size. This year the DDF Summit will be limited to just 500 people, in order to maintain the quality of the networking and comfort for participants. This means that there will only be 250 delegate tickets available. So, don’t waste time in getting yours.

Key themes for 2020 include:

• New modalities research opportunities and challenges
• Personalised therapies, mRNA, Cell and gene therapies
• Analytical techniques for biotherapeutics
• 3D printing, flexible manufacturing techniques, continuous manufacturing
• Multivariate analysis techniques, production process optimisation, digitalisation of
pharmaceutical development
• mAb and bispecific formulation development
• Oral delivery of biologics and other routes
• Device development, microneedles, connected devices
• Integrating human factors into device development, behavioural design

Have a look at our 2020 agenda here or download our brochure

We are now looking for speakers for the 2020 Summit. If you have a case study to share or a speaker to suggest, please contact ahmed.osman@markallengroup.com.

Download 2020 Brochure

2020 Speakers

Anand Subramony

AstraZeneca

Vice President, External Innovation & Novel Technologies

Conference Chairperson

Andreas Abend

Merck

Director Analytical Sciences

Andrew Lewis

Quotient Sciences

Vice President, Pharmaceutical Sciences

Anne Moore

University College Cork

Professor

Bertil Abrahamsson

AstraZeneca

Senior Principal Scientist

Birgit Steiner-Zitzenbacher

Fresenius Kabi

Vice President Innovation & Development Centre Europe

Brian K. Meyer

MSD

Principal Scientist New Technologies, Vaccine Drug Product Development, Bioprocess Research and Development

Charles Evans

MedPharm

VP of Pharmaceutical Development

Claus-Michael Lehr

Helmholtz Institute for Pharmaceutical Research Saarland

Head of the Department Drug Delivery

Cornelia Kruettli

Roche

Section Head Product Care Device and Packaging Development

Daniel Bonner

PureTech Health

Vice President

Davide Mercadante

Biogen

Senior Device Quality Engineer III, Device Development Quality

Dennis Douroumis

University of Greenwich

Professor in Pharmaceutical Technology and Process Engineering, Director of Centre for Innovation in Process Engineering and Research (CIPER)

Dr Chris McConville

Sir Robert Aitken Institute for Medical Research University of Birmingham

Senior Lecturer in Pharmaceutics, Drug Formulation and Delivery

Dr Vivek Trivedi

University of Kent

Lecturer, Formulation Science Department of Pharmaceutical, Chemical and Environmental Sciences

Dr. HDR Denis Spitzer

UMR ISL/CNRS/UNISTRA

Founding Director of the NS3E laboratory, Mixed Research Unit

Dr. Sharareh Salar-Behzadi

Research Center Pharmaceutical Engineering (RCPE)

Principal Scientist

Feng Zhang

University of Texas at Austin

Assistant Professor

Ferdinand Brandl

BASF SE, Nutrition and Health, Development Pharma Solutions

Head of Laboratory

Gregoire Schwach

Roche

Head Drug Delivery

Heinrich Haas

BioNTEch RNA Pharmaceuticals

Vice President RNA Formulation & Drug Delivery

James Humphrey

Croda

Applications Specialist

Jatin Patel

Constellation Pharmaceuticals

Executive Director-CMC

Jean Alié

Sanofi

Head of Section at Sanofi Solid State Characterization and 3D printing

Jean-René Authelin

Sanofi

Global Head of Pharmaceutical Engineering

Johannes Khinast

Graz University of Technology

Director Research Center Pharmaceutical Engineering

Jonas Fransson

Swedish Orphan Biovitrum AB

Director of Drug Product Development

Jonathan Armer

F-Star

Scientist

Kristin Lehmkemper

AbbVie

Senior Scientist

Mara van Haandel

DFE pharma

Innovation Manager

Mike Tate

Boehringer Ingelheim

Human Factors Manager

Mike Tobyn

Bristol-Myers Squibb

Research Fellow

Mostafa Nakach

Sanofi

Head of formulation and process development Biologics Drug Product Development

Muriel Didier

Novartis

Head Human Factors

Nima Aghajari

Sanofi

Senior Simulation Engineer

Omar Naneh

Lek d d. (Novartis)

Senior scientist BPD DPD Operational Sciences

Otmane Boussif

Novartis

Global Head Cell & Gene Therapy Technical Development

Paolo Avalle

MSD

Associate Principal Scientist

Patrick Garidel

Boehringer Ingelheim

Associate Director Protein Science

Room 2 Chairperson

Pekka Kallunki

Lundbeck

Principal Scientist

Philippe Lienard

Sanofi

Pre-Development Science Project Manager

Professor Ijeoma F. Uchegbu

UCL School of Pharmacy

Pro-Vice Provost - Africa and The Middle East Chair in Pharmaceutical Nanoscience

Professor Ijeoma Uchegbu

UCL School of Pharmacy

Chair in Pharmaceutical Nanoscience

Professor Khuloud Al-Jamal

King’s College London

Chair of Drug Delivery & Nanomedicine

Rene Holm

Janssen

Head and Scientific Director, Liquids & Parenterals

Richard Green

Pfizer

Senior Director, Pharmaceutical Sciences

Rémy Kohler

Roche

Human Factors Engineer, Device and Packaging Development, PTDE-D

Satya Kishore Ravuri

Roche

Senior Group Leader, Early-Stage Pharmaceutical and Processing Development

Serge Mathonet

Sanofi

Global Regulatory Affairs Biologics Center CMC Interface

Shalini Andersson

AstraZeneca

Chief Scientist New Therapeutic Modalities

Sonoko Kanai

AstraZeneca

Associate Director

Sudhakar Garad

Novartis Institutes for BioMedical Research

Global Head of Chemical and Pharmaceutical Profiling

Sven Stegemann

Graz University of Technology

Professor for Patient Centric Drug Development and Manufacturing

Thomas Schmidt

Sandoz

Principal Scientist

Thomas Kipping

Merck

Head of Drug Carriers

Torsten Kneuss

Bayer

QA Manager Combination Products

Twinkle Christian

Amgen

Process Development Scientist, Drug Product Technologies department

Werner Hoheisel

Invite

Group Lead Formulation Technologies

Yash Kapoor

MSD

Principal Scientist

Dr. Andreas Seidl

LEUKOCARE AG

Chief Operating Officer

Dr. Andreas Sauer

SE Tylose GmbH & Co. KG

Technical Sales Director

Download 2019 Brochure

×